Background Post-partum family planning services can prevent maternal and child morbidity and mortality in lowresource settings. We assessed the effect of a family planning intervention package on modern contraceptive use at 12 months post partum in predominantly rural Burkina Faso.
Introduction
Spacing birth-to-pregnancy intervals by at least 2 years and birth-to-birth intervals by at least 3 years could prevent more than 30% of maternal and 10% of infant mortality. 1 WHO defines post-partum family planning (PPFP) as the prevention of unwanted pregnancies and closely-spaced pregnancies during the first 12 months after delivery when pregnancy poses the greatest risk to mother and baby. Hence, the aim of PPFP services is to help women and couples to decide on the method they want to use, to initiate that method, and to continue use for ideally 2 years or longer, depending on their reproductive intentions. 2 Birth-to-pregnancy intervals in 50% or more of pregnancies in low-income and middle-income countries are too short-at less than 23 months. 3 The unmet need for family planning in the post-partum period of 12 months is high and far exceeds the unmet need for family planning of women who are not in the postpartum period. Depending on the definitions of unmet need for PPFP and according to estimates derived from Demographic and Health Survey data analysis from 57 countries, including 32 in sub-Saharan Africa, the proportion of post-partum women who want to postpone another child for at least 2 years but are not using contraception ranges from 32% (risk assumed to resume at the end of amenorrhoea) to 62% (risk assumed to resume soon after birth and before the sixth week post partum [given that pregnancy can occur even before menses return]). 4 With the definition that the risk is assumed to resume soon after birth and before the sixth week post partum, the unmet need the year after birth was 65% in east and southern Africa and even reached 75% in west and central Africa. 4 In the footsteps of FP2020, a global initiative to reprioritise family planning as a development objective, a PPFP movement was initiated in 2015 to address this high unmet need.
According to the most recent Demographic and Health Survey data available from Burkina Faso (2010), the median duration of breastfeeding is 24 months (0·6 months for exclusive breastfeeding), the median post-partum sexual abstinence is 8 months, and the median duration of amenorrhoea is 12 months. 5 The median birth interval is 36 months, yet 13% of babies are born less than 24 months after their previous sibling. Most women (95%) attend antenatal care and deliver in a health facility (66%). Postnatal care is offered to 72% of post-partum women within 48 h of childbirth, and 81% of children 12−23 months receive all recom mended vaccines. Despite this high uptake of routine reproductive, maternal, newborn, and child health services that offer frequent contact points to address the contraceptive needs of post-partum women and couples, 6 the unmet need for family planning among post-partum women is high at 89% right after birth, 50% after 6 months of amenorrhoea, and 21% at the end of amenorrhoea. The unmet need among all married women of reproductive age is also high at 24%. 4 In 2015, data from the United Nations showed that maternal mortality remained high in Burkina Faso (371 of 100 000 live births), as did the total fertility rate (5·4 children per woman). 7 PPFP is usually designed as an integral part of reproductive, maternal, newborn, and child health services. Although advances in access to these services in many sub-Saharan African countries, including Burkina Faso, have been observed in recent decades, progress is slow regarding effective post-partum contraceptive use. 3, 8, 9 The evidence is often weak or
Research in context
Evidence before this study On Aug 11, 2018, we searched PubMed using the term "randomized controlled trial" combined with "postpartum" and "family planning" or "contraception" for publications in English focusing on trials in developing countries. We identified five trials since the last systematic review, which was published in 2016. All five trials were in Africa (Burkina Faso, Egypt, Kenya, Rwanda, and Uganda) and investigated a specific intervention. The urban-based Burkina Faso study showed that involving male partners of pregnant women in maternity care through group sessions targeting only men and couple counselling sessions before and after childbirth resulted in marginal differences in the use of any contraceptives at 8 months post partum between the intervention group (71%) and control group (64%), with a risk ratio of 1·10 (95% CI 1·02−1·20). The university hospital-based Egyptian study, which recruited pregnant women who were planning to space their next pregnancy and breastfeed for at least a year, confirmed previous findings: in-advance counselling and provision of emergency contraceptive pills had a significant effect on the proportion of unplanned pregnancies at 6 months post partum between the emergency contraceptive pill and lactational amenorrhoea group (0·4%) and lactational amenorrhoea only group (5·3%) (p=0·0001). In Kenya, the use of mobile phone short message service sent weekly to urban women in the antenatal and post-partum period did not show a difference in contraceptive use at 10, 16, or 24 weeks post partum. In Rwanda, post-partum family planning (PPFP) services integrated into immunisation clinics appeared to be feasible, acceptable, and effective in increasing modern contraceptive use (49% of women at baseline against 57% at endline in the intervention group), although it is important to note that these were different groups of women (in the control group, the proportion of women using a modern method was 58% at baseline and 50% at endline). The university hospital-based Ugandan study recruited women just after childbirth who wanted a contraceptive implant upon receiving comprehensive contraceptive counselling. Implant use at 6 months was higher among women who had insertion before hospital discharge (97%) versus those who chose to delay insertion to 6 weeks post partum (68%; p<0·001).
Added value of this study
The Yam Daabo study did not investigate a specific programmatic innovation or the promotion of a particular PPFP method-fertility and contraceptive choices were made by the women and couples. This cluster-randomised controlled trial showed that a package of six low-technology interventions, designed in a participatory manner and aimed at strengthening routine antenatal and postnatal services in primary health clinics in predominantly rural settings (ie, refresher training of service providers, regularly scheduled and strengthened supportive supervision of providers, enhanced availability of services 7 days a week, a PPFP counselling tool, appointment cards for women, and invitation letters for partners), doubled the proportion of women using short-acting and long-acting reversible modern contraceptives up to 12 months post partum when compared with women using routine care.
Implications of all the available evidence
On the basis of the growing body of evidence on PPFP, decision makers can opt for different strategies to strengthen contraceptive use depending on health service needs, gaps, and opportunities of specific contexts. These strategies include the Yam Daabo approach, which aimed to reinforce existing routine services through a package of different interventions. Although cost-effectiveness of the package warrants further study, the low technology of the interventions and focus on strengthening existing services at the primary health-care level make it suitable for large-scale implementation in similar settings in Burkina Faso and other countries.
incomplete in terms of study design and quality, intervention details, or women's perspectives according to various literature reviews. 10−12 Additionally, knowledge gaps still exist, particularly regarding studies that look at operationally feasible ways to integrate PPFP into existing antenatal care and postnatal care (eg, by meaningfully engaging community stakeholders). 2 To address the high unmet need for PPFP, the objective of Yam Daabo (ie, "your choice" in Mooré, one of the local languages in Burkina Faso) was to determine the effectiveness of a PPFP intervention package designed applying participatory action research on the use of contraceptive methods during the first year post partum. In anticipation of potential dissemination of the Yam Daabo strategy, the trial took place in rural and urban settings and in two countries (ie, Burkina Faso and the Democratic Republic of Congo); here, we report the results of the Burkina Faso trial.
Methods

Study design and participants
The study was implemented in Passoré province, Northern Region and one of the poorest areas of Burkina Faso, in the rural villages of Arbole, Bagaré, Bouré, Gomponsom, Samba, and Tema, and the urban Sectors of Yako (Secteur 5 and Secteur 6). Further details on Burkina Faso and the study sites are provided in the appendix, pp 2−3.
Yam Daabo was a pragmatic two-group, clusterrandomised, multi-intervention trial done in eight primary health centres, at the level of which randomisation to control and intervention arms occurred (see published protocol). 13 The cluster randomised controlled trial design was justified by the fact that three of the six components of the PPFP package were not delivered directly to individual participants but only implemented at the facility level. In addition, the cluster design avoided potential contamination between intervention and control groups for the other three individual-based interventions. Participants randomly allocated to the intervention group received the PPFP intervention package whereas individuals randomly allocated to the control group received routine health care.
The study was done in centres offering reproductive, maternal, newborn, and child-health services. Further details of the sampling calculation are provided in the published protocol. 13 Health centres were eligible if they offered the continuum of antenatal care, delivery, and postnatal care; had at least three modern contraceptive methods available, including a barrier method such as condoms, a short-term method such as pills, a long-term method such as intrauterine devices, and referrals for permanent methods; had no stock-outs of contraceptives during the preceding 6 months; had on average at least 30 deliveries per month; were situated within a 4 h drive from the research centre; and were willing to participate. All pregnant women attending the health centres for antenatal care were invited to participate in the study. They were eligible if they were in their third pregnancy trimester; their health and pregnancy situation allowed for a birth at the health centre; they had the intention to attend antenatal care, delivery, and postnatal care at the health centre; they were not participating in another study; and they provided informed consent (and assent for minors of <18 years old).
Randomisation and masking
The eight sites were matched in pairs according to the number of monthly deliveries, the ratio of health workers per population in the health zone, and the setting (ie, rural, urban). Within each of the four pairs, we randomly assigned a site to the intervention group or to the control group. This randomisation was done four times (once for each pair). No restriction in the randomisation process was required. All consecutive and eligible participants were included in the clusters. Due to the nature of the interventions, participants, health staff, research assistants assigned to each centre, and the rest of the research team members could not be masked to the cluster assignments. Only data analysts were masked to the allocation assignment (ie, they received no information about the cluster allocation and did not interact with the field team).
Study approval was obtained by the ethics committee in Burkina Faso (reference number: 2016-02-019) and WHO Research Ethics Review Committee, Geneva, Switzerland (Protocol ID RPC757). All adult participants provided written consent. Minors gave their informed assent and their respective parents or guardians their informed consent.
Intervention package
The rationale for our approach is based on the WHO seminal publication in 2013 of Programmatic strategies for postpartum family planning, and three other systematic reviews of the literature (without meta-analysis) on PPFP interventions in less developed countries published between 2014 and 2016. 2, 11, 12, 14 These documents suggest that the following interventions may have a positive effect on post-partum contraceptive uptake: counselling activities during antenatal care; provision of PPFP information, education, and counselling materials before women are discharged home from health facilities, including provision of emergency contraception backup for users of the lactational amenorrhoea method; promotion by community-based counsellors of exclusive breastfeeding practices before 5−6 months post partum; access to contraceptive methods immediately after childbirth, including intrauterine devices; provider competencies in quality counselling and the provision of quality services with a range of readily available products; and longer programmes with several contact points between providers and clients across the continuum of care versus short antenatal interventions.
See Online for appendix Our PPFP intervention package comprised three facilityoriented interventions (ie, refresher training of service providers, regularly scheduled and strengthened supportive supervision of providers, enhanced availability of services 7 days a week), and three individual-based interventions (ie, a PPFP counselling tool, appointment cards for women, and invitation letters for partners). The package was designed through participatory action research and the process and contents are detailed elsewhere. 15, 16 Participants received individual-based interventions during third-trimester antenatal care visits and postnatal care follow-up visits, according to national practice (typically on clinical discharge [24−48 h], at 6 days, 6 weeks, then at months 6 and 9, before the trial exit at month 12 post partum).
The working hypotheses for the selection of the PPFP interventions to be included in the package were as follows. They should strengthen existing antenatal care and postnatal care services by means of so-called lowdose, high-frequency interventions (which we assumed would be more effective than high-dose, low-frequency strategies that promote a specific method over another and restrict services to a narrow time window, such as before home discharge after childbirth, or during the 6-week postnatal care visits dedicated to PPFP); meaningfully engage key actors, including clients and providers, in the design, implementation, and research to better reflect field reality (including limited human resources and clinical capacity), and ensure its feasibility, sustainability, and scalability to other settings; be in line with national health policies; and take into consideration the scarcity of public resources.
The WHO team in Geneva developed the paper-based study case report forms with inputs from the country researchers who tested advanced drafts with an appropriate sample of mock clients from sites included in the formative study phase. Data were collected by trained research assistants, irrespective of whether women attended clinic visits after enrolment. Data entry was performed in Ouagadougou and checked in Geneva by use of OpenClinica (version 3.11).
Outcomes
The primary outcome was prevalence of modern contraceptive use at 12 months post partum (assessed on the first day of month 12). We amended our original protocol to extend the follow-up period from months 9 to 12 post partum to allow for better comparability with other published research, after the initial funder's research grant deadline was chosen. This extension was approved by Ethics Committees at WHO Headquarter and country level. We also report two secondary outcomes: prevalence of modern contraceptive use at 6 weeks (assessed at 45 days), which coincides with the PPFP-dedicated visit as per national recommendations, and prevalence of modern contraceptive use at 6 months (assessed on the first day of month 6), which corresponds to the latest point when transition from the lactational amenorrhoea method to another method should occur. We acknowledged the limitations of using prevalence of modern contraceptive use as an outcome: there is potential for contraceptive uptake to be encouraged to achieve targets, without accounting for women's or couples' fertility intentions and their right to determine the timing and spacing of their children.
We followed WHO recommendations for medical eligibility to define modern contraceptives appropriate up to 12 months post partum. 17 We categorised modern contraceptives as follows: long-acting and reversible contraceptives, including implants and intrauterine devices; short-acting contraceptives, including injectable, pills, emergency contraception, and male and female condoms, among others; permanent methods (male and female sterilisation); and lactational amenorrhoea. Contraceptives were further defined as "modern and appropriate" and "non-modern or non-appropriate". Non-modern were traditional methods, withdrawal, and abstinence. Non-appropriate were lactational ameno rrhoea if used after 6 months and calendar-based methods if used during the first 12 months post partum. We assumed that as most women breastfeed for up to 2 years, they would not fulfil the initiation requirement of having at least three regular menstrual cycles before 12 months.
Statistical analysis
The sample size was estimated on the basis of the following assumptions. Women in the intervention group wanting to limit or space their pregnancies would already use a modern contraceptive method at 6 months, when the lactational amenorrhoea method is no longer indicated. Therefore, although the main study outcome was prevalence of modern contraceptive use at 12 months post partum, we used country data at 6 months to set our sample size. The sample size was estimated with the 2010 Demographic and Health Survey data: 5 we assumed a 5% modern contraceptive uptake in the control group (based on 7% of prevalence of modern contraceptive use among women using traditional or modern methods at 6 months post partum), and an increase to 20% in the experimental group (based on 15% of prevalence of modern contraceptive use among women in the general population, to which we added 5% given the high unmet need for PPFP). Assuming an intracluster (health centre) correlation coefficient of 0·02 (no specific evidence existed for its value from the literature), 18 the intervention group and the control group had each four study sites with at least 60 participants per site. This number allowed for a statistical power of 93% to detect a difference of 15% to a level of significance of 5%. Assuming a 10% participant loss to follow up, each facility recruited at least 70 pregnant women. This equated to a cohort of at least 280 pregnant women in each study arm (four sites with 70 participants each), and in total at least 560 participants (appendix, pp 4-5).
Data from all eligible participants were analysed with IBM SPSS Statistics (version 21.0), R (version 3.4.3), and WINPEPI (PEPI-for-Windows, version 11.50). Generalised linear mixed models (log binomial and log Poisson) were used to assess the effect of the package on prevalence ratios (PRs) of main outcomes with 95% CIs, comparing intervention and control groups while accounting for clustering and adjusting for potential confounders (women's baseline characteristics that were imbalanced between groups). Fisher's exact test was used for statistical significance of differences in outcomes between groups when samples were small, and models did not converge. WINPEPI was used to obtain a post-hoc global estimation of the intracluster correlation coefficient. We did a modified intention-to-treat analysis that included all women irrespective of whether they continued to visit the clinic after enrolment. Because women had to see a provider to receive the intervention package, we planned to do a per-protocol analysis focused on participants who attended all recommended follow-up visits. The study is registered with the Pan African Clinical Trials Registry (PACTR201609001784334).
Role of the funding source
The study funder had no role in study design, data collection, data analysis, data interpretation, or writing the Article. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.
Results
From July 27-Oct 17, 2016, 20 primary clinics were assessed for eligibility, where four clinics were randomly assigned to the intervention group and four to the control group (figure). Of 614 women asked to participate, 571 were enrolled in the study (286 received the inter vention package, 285 received routine care), of whom 523 (260 in the intervention group, 263 in the control group) completed the 12 month study exit interview. Timely visits and missed visits between the intervention and control groups differed significantly at 6 weeks Some baseline differences were noted between the intervention and control clusters (table 1), including length of exclusive breastfeeding of last child, interpregnancy intervals, ability to read among male partners, and usual travel time needed to get to the health centre.
At 12 months post partum, prevalence of modern contraceptive use in the intervention arm was about twice that of the control arm (55% vs 29%, adjusted prevalence ratio [PR] 1•79, 95% CI 1•30-2•47); the ratio was similar for both short-acting contraceptives or long-acting and reversible contraceptives (table 2) . At 6 months, prevalence of modern contraceptive use (which included the lactational amenorrhoea method) in the intervention group was more than double that in the control group (59% vs 24%, adjusted PR 2•31, 1•44-3•71) and at 6 weeks post partum, prevalence of modern contraceptive use (including lactational amenorrhoea) in the intervention group was four times that in the control arm (42% vs 10%, adjusted PR 3•88, 1·46-10·35). No women used the lactational amenorrhoea method in the control group versus a significantly higher proportion of about one in ten women in the intervention group at both 6 weeks and 6 months post partum (table 2) . In terms of the mix between methods, within each of the trial arms, the distribution between short-acting contraceptives and long-acting and reversible contraceptive users was approximatively even, with slightly more short-acting contraceptive users at 6 weeks and 6 months, and slightly more long-acting and reversible contraceptives users at 12 months (table 2) . Implant was by far the preferred method among long-acting and reversible contraceptives users (appendix). There was no male or female sterilisation. The post-hoc global estimation of the intracluster correlation coefficient was 0•036 (0•064 for the intervention group and 0•009 for the control group).
Discussion
Overall, our results showed that the implementation of a package of six low-technology PPFP interventions was an effective strategy to increase the use of modern 
Maternity and contraception
Previous pregnancies contraceptives for up to 12 months post partum in women in a predominantly rural region of Burkina Faso. In both arms, the prevalence of modern contraceptive use increased from 6 weeks to 6 months and remained relatively steady until 12 months. The prevalence of modern contraceptive use among participants in the control arm at 6 months was at a level similar to that of the projected prevalence for 2017 among married women in Burkina Faso (25%). 19 In comparison, the prevalence among participants who received the package of interventions (23•4% without the lactational amenorrhoea method) had reached the national prevalence among married women by 6 weeks, before increasing to more than twice the national prevalence at 6 months and 12 months.
The modern contraceptive method mix at 12 months within both study arms reflected that reported in the general population in Burkina Faso from 2014 to 2015 (ie, 40% implants, 35% injectables, 13% pills, 8% male condoms, 3% intrauterine device, and other methods). 20 Our low-dose, high-frequency approach required women to attend the routinely recommended followup visits for timely adoption of contraceptives. Client counselling, supported by the PPFP tool, combined with the provision of appointment cards, might have contributed to the marked differences in timely visits between women in the intervention and control groups at 6 weeks and 6 months, although the proportion reduced in both groups over time and no women attended all the follow-up visits.
As for the use of the lactational amenorrhoea method at 6 weeks and 6 months post partum, although there was a significant difference between the intervention and control arms, our results contrast with the 2010 Demographic and Health Survey findings that showed that 25% of infants younger than 6 months were exclusively breastfed. 5 Early supplementation rooted in customary practices are reported to be common 21 and might explain our results as well as the stagnant median duration of exclusive breastfeeding in Burkina Faso (0·4 month in 1993 and 0·6 month in 2010), which reflects the situation in other low-income countries. 22 Also according to the 2010 Demographic and Health Survey, the median duration of amenorrhoea was 12 months and suggests that breastfeeding, although not exclusive, must be frequent enough to induce amenorrhoea. Therefore, our intervention package covered lactational amenorrhoea benefits, requirements, and limitations in the PPFP counselling tool along with information on other effective contraceptive options. Our package did not include a targeted promotion of the lactational amenorrhoea method by health staff because it was not perceived as an efficient use of limited resources, 15 although studies in sub-Saharan Africa showed that such promotion can increase the prevalence of exclusive breastfeeding (eg, through peer counsellors 23 or the Ten Steps to Successful Breastfeeding 24 ). In fact, most lactational amenorrhoea method users came from a single intervention study site (Bouré), where the main service provider was found to be deeply convinced by the benefits of the lactational amenorrhoea method and counselled on it.
To our knowledge, Yam Daabo is the first study using a PPFP package approach in Africa. Its results add to the body of evidence regarding the effectiveness of various packages of different interventions on postpartum contraceptive use, which is relatively sparse. The package strategy has previously been shown to result in earlier and increased use of contraception by post-partum women in two studies with preintervention and postintervention designs that were implemented in 2002 in Guatemala 25 and in 1998 in Russia. 26 They tested a comprehensive package of maternal and child health interventions, including PPFP, in the postnatal period. In Guatemala, the interventions took place at primary and secondary levels of care and comprised information education and counselling materials, training of providers, and monitoring at the facility and community levels; the proportion of women using a modern contraceptive three months after birth increased from 18% to 25%. In Russia, the package comprised the provision of supplies, training providers, and quality of care improvement in a women's hospital; before being discharged home, 65% of post-partum women adopted a modern contraceptive method following the intervention Data are n/N (%), unless indicated differently. Point and interval estimations were obtained using log binomial or log Poisson models for prevalence ratios. *Accounting for clustering and adjusted for usual travel time to health centre and ability to read an official language (among partners). †Fisher's exact test, two-sided p value <0·001. Table 2 : Use of contraceptive methods at 6 weeks, 6 months, and 12 months post partum as compared to 0% before. Neither of the two studies had a longer follow-up to assess change in contraceptive use. In contrast to theses studies, which did not directly focus on PPFP, and to studies investigating specific PPFP methods or approaches (with most of them assessing modern contraceptive prevalence at 6 months or less), our research focused on PPFP within an overall approach of strengthening routine antenatal care and postnatal care services. Moreover, modern contraceptive prevalence in our trial was assessed up to 12 months after childbirth. Our study also stands out as it did not investigate a specific programmatic innovation or the promotion of a particular PPFP method: fertility and contraceptive choices were up to the women and couples, and concentrated on primary health-care centres, given the growing availability of antenatal care, delivery, and postnatal care services at primary care level in lowresource settings, including rural areas. This offers enhanced client-provider contact points to minimise missed health services opportunities to address the contraceptive needs of postpartum women and couples. Our study also contributes to a global (a posteriori) estimation of the intracluster correlation coefficient, which was about 0·03, somewhat larger than the initially-assumed value of 0·02 (under this assumption of 0·03, the power is above 80%).
Our trial has several limitations. First, despite being randomised, the study included a total of eight clusters, which was sufficient according to our statistical hypotheses but is relatively modest and therefore at increased risk of groups not being fully similar. However, when controlled for differences in baseline characteristics, the results did not change substantially (the unadjusted PR at 12 months was 1•90). Second, the nature of this pragmatic facility-based trial did not allow blinding of participants, providers, and interviewers, and we cannot rule out assessment bias nor a Hawthorn effect. Third, although we used independent interviewers, we also cannot exclude an enhanced effect size due to a bias towards socially desirable answers especially in this facility-based research. Fourth, the paired urban study sites were both in Yako and we cannot exclude intervention contamination. However, a Hawthorn effect, information and assessment bias, and contamination alone cannot contribute to the large contraceptive use reported at different measurement points. Fifth, policy makers and programme managers might wish to implement a single most effective intervention. Our trial design does not allow one to distinguish which intervention in the package had the greatest effect on contraceptive use, for which further research would be required. However, interventions were chosen based on multiple stakeholder perspectives and integrated into the package because they were perceived to be of low-technology, adapted to resourcelimited settings, while strengthening existing services and therefore easily feasible and replicable. Sixth, women using modern contraceptives at 12 months would require follow-up until 2 years and beyond to study their patterns of contraceptive use and assess whether they continue to be more successful in spacing or limiting pregnancies according to their reproductive choices.
The implementation of a package of six low-technology PPFP interventions designed in a participatory manner to strengthen the continuum of antenatal care and postnatal care services in every day care in primary health clinics significantly raised the proportion of women using the lactational amenorrhoea method up to 6 months post partum and short-acting and long-acting reversible modern contraceptives up to 12 months post partum. The large-scale implementation of a similar package in similar settings could contribute to decreasing the unmet need for post partum family planning among women and couples and increasing the likelihood of meeting FP2020 goals.
